These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16640451)

  • 1. The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.
    Fagiolino P; Eiraldi R; Vázquez M
    Clin Pharmacokinet; 2006; 45(5):433-48. PubMed ID: 16640451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of circadian rhythms on the kinetics of drugs in humans.
    Baraldo M
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):175-92. PubMed ID: 18248311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic crisis in the elderly.
    ElDesoky ES
    Am J Ther; 2007; 14(5):488-98. PubMed ID: 17890940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.
    Hämmerlein A; Derendorf H; Lowenthal DT
    Clin Pharmacokinet; 1998 Jul; 35(1):49-64. PubMed ID: 9673834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
    Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
    Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug dosage in the elderly. Is it rational?
    Turnheim K
    Drugs Aging; 1998 Nov; 13(5):357-79. PubMed ID: 9829164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions.
    Corsonello A; Pedone C; Incalzi RA
    Curr Med Chem; 2010; 17(6):571-84. PubMed ID: 20015034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies.
    van den Broek MP; Groenendaal F; Egberts AC; Rademaker CM
    Clin Pharmacokinet; 2010 May; 49(5):277-94. PubMed ID: 20384391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
    Chen ML
    Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulation of differential drug pharmacokinetics under heat and exercise stress using a physiologically based pharmacokinetic modeling approach.
    Sidhu P; Peng HT; Cheung B; Edginton A
    Can J Physiol Pharmacol; 2011 May; 89(5):365-82. PubMed ID: 21627485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging biology and geriatric clinical pharmacology.
    McLean AJ; Le Couteur DG
    Pharmacol Rev; 2004 Jun; 56(2):163-84. PubMed ID: 15169926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological determinants of altered pharmacokinetics in the elderly.
    Shand DG
    Gerontology; 1982; 28 Suppl 1():8-17. PubMed ID: 7044905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic dosage guidelines for elderly subjects.
    Turnheim K
    Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):33-48. PubMed ID: 16922651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.
    Staatz CE; Tett SE
    Drugs Aging; 2005; 22(7):541-57. PubMed ID: 16038570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental Changes in Pharmacokinetics and Pharmacodynamics.
    van den Anker J; Reed MD; Allegaert K; Kearns GL
    J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S10-S25. PubMed ID: 30248190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic parameters: which are necessary to define a drug substance?
    Benet LZ
    Eur J Respir Dis Suppl; 1984; 134():45-61. PubMed ID: 6586486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics in infants and children. A reappraisal.
    Kearns GL; Reed MD
    Clin Pharmacokinet; 1989; 17 Suppl 1():29-67. PubMed ID: 2692939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
    Shah RR
    Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic studies in pregnancy.
    Avram MJ
    Semin Perinatol; 2020 Apr; 44(3):151227. PubMed ID: 32093881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A paradigm shift in pharmacokinetic-pharmacodynamic (PKPD) modeling: rule of thumb for estimating free drug level in tissue compared with plasma to guide drug design.
    Poulin P
    J Pharm Sci; 2015 Jul; 104(7):2359-68. PubMed ID: 25943586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.